Walmart is expanding its abortion coverage for employees after following the Supreme Court ruling that scrapped a nationwide right to abortion.
In a memo sent to employees, Walmart, the largest employer in the US, said its health care plans will now cover abortion for employees when there is rape or incest, or there is a health risk to the mother, ectopic pregnancy, miscarriage, or lack of fetal viability.
Walmart’s benefits plan had covered abortion only in cases when the health of the mother would be in danger if the fetus were carried to term, if the fetus could not survive the birthing process, or if death would be imminent after birth.
According to Walmart’s chief people officer, Donna Morris, the new policy will also offer “travel support” for workers seeking abortions covered under its health care plans, as well as their dependents, to enable them to access services that are not available within 100 miles of their locations.
Abortion is illegal in Arkansas, where the company is based unless it is required to save the mother's life in the event of a medical emergency.
The revised policy allows Walmart employees to travel outside of the state or any other state that prohibits abortion for rape and incest to obtain the procedure through the retailer's health plans.
In the United States, Walmart employs nearly 1.6 million people.


Merck Raises Growth Outlook, Targets $70 Billion Revenue From New Drugs by Mid-2030s
TrumpRx.gov Highlights GLP-1 Drug Discounts but Offers Limited Savings for Most Americans
Australian Scandium Project Backed by Richard Friedland Poised to Support U.S. Critical Minerals Stockpile
Gold and Silver Prices Slide as Dollar Strength and Easing Tensions Weigh on Metals
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Sanofi’s Efdoralprin Alfa Gains EMA Orphan Status for Rare Lung Disease
Global Markets Slide as AI, Crypto, and Precious Metals Face Heightened Volatility
Federal Judge Rules Trump Administration Unlawfully Halted EV Charger Funding
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
U.S. Condemns South Africa’s Expulsion of Israeli Diplomat Amid Rising Diplomatic Tensions
Panama Supreme Court Voids Hong Kong Firm’s Panama Canal Port Contracts Over Constitutional Violations
Viking Therapeutics Sees Growing Strategic Interest in $150 Billion Weight-Loss Drug Market
Novo Nordisk Launches Once-Daily Wegovy Pill in U.S. at Competitive Pricing
Newly Released DOJ Epstein Files Expose High-Profile Connections Across Politics and Business
China to Add Eli Lilly’s Mounjaro to National Health Insurance in 2025
Ford and Geely Explore Strategic Manufacturing Partnership in Europe 



